Vera Therapeutics, Inc.
- VERA
- NASDAQ
- Biotechnology
- Immunology (Atacicept)
- Clinical-Stage Biotech
$27.88
Today −2.42%Quote Oct 16, 2026, 08:00 PM UTC
−18.65%over the last month
Max drawdown −26.3%From 1-month high −23.1%3 months −24.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$2.01B
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$80.89
+190.1% from here
Floor
$27.29
2.1% below price
Where the price sits
14 analysts
Analyst range, low to high
$34.00$125.00
- Price $27.88
- Resistance $28.59
- Consensus $80.89
The price is right under resistance. Analysts' average target sits about 190% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VERAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
361
Founded
2016